BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of CEBM & Programs in EBHC
- NHS Urgent Care GP
- NIHR Senior Investigator
Carl Heneghan is a clinical epidemiologist with expertise in evidence-based medicine, research methods, and evidence synthesis.
He is Director of the NIHR SPCR Evidence Synthesis Working Group a collaboration of nine primary care departments across UK universities. He set up and directs the Oxford COVID Evidence Service, has over 400 peer-reviewed publications (current H index 72); published 95 systematic reviews. He is a Contact Editor in the Cochrane Acute Respiratory Infection group and Editor of the Catalogue of Bias.
His work includes investigating drugs and devices, advising governments on regulatory evidence, working with the media assessing health claims and research on common presenting conditions in primary care.
He has investigated the evidence for antivirals Tamiflu, acute respiratory infections, IVF 'add-on' treatments, metal-hips, cancer screening, health-checks, surgical mesh, medical devices and hormone pregnancy tests.
He is a clinical advisor to two UK All Parliamentary Party Group on Surgical Mesh and Hormone Pregnancy Tests, an adviser to the WHO clinical trials registry platform and a founder of the AllTrials campaign; twice he was voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status.
In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching. He is Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM, and is Director of Programs in Evidence-Based Health Care,
Dissemination and Media: See find an expert page
Global Centre for Healthcare and Urbanisation (GCHU)
He is co-director of the GCHU based at Kellogg College that has been established to foster a better understanding of the interaction between healthcare and urbanisation to make urban centres environmentally, economically, and socially sustainable, and to provide an environment that supports and sustains health and wellbeing.
Conflicts of interest and payments:
He holds grant funding from the NIHR School of Primary Care Research, the NIHR BRC Oxford, and the World Health Organization for a series of Living rapid reviews on the modes of transmission of SARs-CoV-2 reference WHO registration No2020/1077093. He has received financial remuneration from an asbestos case and given legal advice on mesh and hormone pregnancy tests cases. He has received expenses and fees for his media work including occasional payments from BBC Radio 4 Inside Health and The Spectator. He receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract Oxford Health NHS Foundation Trust). He has also received income from the publication of a series of toolkit books and for appraising treatment recommendations in non-NHS settings and for undertaking evidence reviews. He is the Director of CEBM and is an NIHR Senior Investigator. He is an advisor to Collateral Global, to the Sir James Mackenzie Institute for Early Diagnosis at St Andrew's University, the WHO's International Clinical Trials Registry Platform (ICTRP) and is a member of the board of Preventing Overdiagnosis.
Brodersen J. et al, (2018), BMJ evidence-based medicine, 23, 1 - 3
Nunan D. et al, (2017), Evidence-Based Medicine, 22, 202 - 204
Hayward GN. et al, (2017), JAMA - Journal of the American Medical Association, 317, 1535 - 1543
Pluddemann A. et al, (2021)
A focused-protection vaccination strategy: why we should not target children with COVID-19 vaccination policy
GIUBILINI A. et al, (2021), Journal of Medical Ethics
Rosca EC. et al, (2021)